Radcliffe Capital Management’s Panacea Acquisition Corp. II Class A Ordinary Shares PANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-199,571
Closed -$2.04M 691
2023
Q1
$2.04M Buy
199,571
+5,598
+3% +$56.7K 0.13% 232
2022
Q4
$1.95M Hold
193,973
0.06% 491
2022
Q3
$1.91M Hold
193,973
0.05% 675
2022
Q2
$1.89M Buy
193,973
+1,200
+0.6% +$11.7K 0.04% 717
2022
Q1
$1.88M Buy
192,773
+42,773
+29% +$415K 0.04% 695
2021
Q4
$1.46M Hold
150,000
0.04% 701
2021
Q3
$1.47M Hold
150,000
0.04% 582
2021
Q2
$1.5M Buy
+150,000
New +$1.5M 0.05% 592

Radcliffe Capital Management's PANA Position: Q2 2023 in Review

Radcliffe Capital Management sold out of Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) in Q2 2023, closing a stake of 199,571 shares — an estimated $2.04M sold.

Radcliffe Capital Management first reported a position in PANA in Q2 2021 and held it in 8 quarters. The position peaked at $2.04M in Q1 2023. 0 funds tracked by Wall St. Rank hold PANA as of Q2 2023.

  • Radcliffe Capital Management reported no remaining Panacea Acquisition Corp. II Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 199,571 Panacea Acquisition Corp. II Class A Ordinary Shares shares in Q2 2023, an estimated $2.04M.
  • Radcliffe Capital Management first reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares in Q2 2021 and held it in 8 quarters.
  • Radcliffe Capital Management's Panacea Acquisition Corp. II Class A Ordinary Shares position peaked at $2.04M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. II Class A Ordinary Shares as of Q2 2023.

Based on Radcliffe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.